GSK3B and cancer: In previous studies, indirubins had been evaluated against a variety of diseases particularly in cancer and neurodegenerative disease therapy studies [8,26–28] and have been shown to be potent inhibitors of mammalian kinases such as CDKs, GSK-3β, DYRKs and Aurora kinases [4,6,18,29].